Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
37.30
-0.53 (-1.40%)
At close: Sep 26, 2025, 4:00 PM EDT
37.33
+0.03 (0.08%)
After-hours: Sep 26, 2025, 4:10 PM EDT
AAPG Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for AAPG.
Price Target: $ (0.00%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for AAPG is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 27, 2025 |
Financial Forecast
Revenue This Year
598.12M
from 980.65M
Decreased by -39.01%
Revenue Next Year
2.80B
from 598.12M
Increased by 368.64%
EPS This Year
-3.14
from -1.34
EPS Next Year
2.37
from -3.14
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 766.5M | 3.4B | |||
| Avg | 598.1M | 2.8B | |||
| Low | 499.2M | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -21.8% | 473.3% | |||
| Avg | -39.0% | 368.6% | |||
| Low | -49.1% | 198.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.47 | 4.84 | |
| Avg | -3.14 | 2.37 | |
| Low | -3.68 | -0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.